Table 4.
PR duration, msa | Abnormal P wave axis | Elevated P wave terminal force in V1 | |||||
---|---|---|---|---|---|---|---|
Diff (95%CI) | P-value | OR (95%CI) | P-value | OR (95%CI) | P-value | ||
Model 1 | −0.82 (−1.63, −0.01) | 0.05 | 0.98 (0.86, 1.11) | 0.72 | 1.05 (0.97, 1.14) | 0.19 | |
Model 2 | −0.69 (−1.52, 0.13) | 0.10 | 0.95 (0.83, 1.09) | 0.45 | 1.01 (0.93, 1.10) | 0.81 | |
Model 3 | −0.69 (−1.52, 0.14) | 0.10 | 0.95 (0.83, 1.09) | 0.45 | 1.01 (0.93, 1.10) | 0.81 | |
Model 1 | 0.15 (−0.66, 0.97) | 0.71 | 0.86 (0.74, 1.00) | 0.04 | 1.11(1.03, 1.20) | 0.01 | |
Model 2 | −0.56 (−1.39, 0.27) | 0.18 | 0.92 (0.79, 1.06) | 0.25 | 1.03 (0.94, 1.12) | 0.55 | |
Model 3 | −0.90 (−1.71, −0.09) | 0.03 | 1.02 (0.89, 1.16) | 0.79 | 1.02 (0.94, 1.11) | 0.68 | |
Model 1 | −0.52 (−1.31, 0.27) | 0.19 | 1.04 (0.92, 1.18) | 0.54 | 1.07 (0.99, 1.16) | 0.09 | |
Model 2 | −0.81 (−1.60, −0.02) | 0.05 | 1.01 (0.89, 1.15) | 0.86 | 1.03 (0.95, 1.11) | 0.51 | |
Model 3 | −0.90 (−1.71, −0.09) | 0.03 | 1.02 (0.89, 1.16) | 0.79 | 1.02 (0.94, 1.11) | 0.68 | |
Model 1 | 0.79 (0.01, 1.57) | 0.05 | 0.92 (0.81, 1.04) | 0.17 | 0.96 (0.88, 1.04) | 0.30 | |
Model 2 | 0.58 (−0.21, 1.37) | 0.15 | 1.00 (0.88, 1.15) | 0.95 | 1.00 (0.92, 1.08) | 0.93 | |
Model 3 | 0.59 (−0.20, 1.38) | 0.15 | 1.00 (0.88, 1.15) | 0.96 | 1.00 (0.92, 1.09) | 0.98 |
Model 1: Adjusted for age, sex, race, study site, and batch. Model 2: As Model 1, additionally adjusted for smoking, body mass index, systolic blood pressure, use of antihypertensive medication, diabetes mellitus, prevalent heart failure and prevalent coronary heart disease. Model 3: As Model 2, additionally adjusted for eGFR
Models additionally adjusted for resting heart rate